Regarding PD-L1 expression levels, the 7-year DFS rates of low vs. high stromal PD-L1 immune cell score and low vs. high tumor PD-L1 H-score were 52% vs. 70% and 72% vs. 21%, respectively. The gene discussed is CD274; the disease is neoplasm.